These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Middlebrooks CD; Banday AR; Matsuda K; Udquim KI; Onabajo OO; Paquin A; Figueroa JD; Zhu B; Koutros S; Kubo M; Shuin T; Freedman ND; Kogevinas M; Malats N; Chanock SJ; Garcia-Closas M; Silverman DT; Rothman N; Prokunina-Olsson L Nat Genet; 2016 Nov; 48(11):1330-1338. PubMed ID: 27643540 [TBL] [Abstract][Full Text] [Related]
28. Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study. Han MR; Deming-Halverson S; Cai Q; Wen W; Shrubsole MJ; Shu XO; Zheng W; Long J Breast Cancer; 2015 Sep; 22(5):544-51. PubMed ID: 24510657 [TBL] [Abstract][Full Text] [Related]
29. Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study. Connor AE; Baumgartner RN; Baumgartner KB; Pinkston CM; Boone SD; John EM; Torres-Mejía G; Hines LM; Giuliano AR; Wolff RK; Slattery ML Mol Carcinog; 2015 Dec; 54(12):1541-53. PubMed ID: 25339205 [TBL] [Abstract][Full Text] [Related]
30. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Fejerman L; Chen GK; Eng C; Huntsman S; Hu D; Williams A; Pasaniuc B; John EM; Via M; Gignoux C; Ingles S; Monroe KR; Kolonel LN; Torres-Mejía G; Pérez-Stable EJ; Burchard EG; Henderson BE; Haiman CA; Ziv E Hum Mol Genet; 2012 Apr; 21(8):1907-17. PubMed ID: 22228098 [TBL] [Abstract][Full Text] [Related]
31. Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort. Vitiello GAF; de Sousa Pereira N; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE J Cancer Res Clin Oncol; 2020 Jun; 146(6):1523-1532. PubMed ID: 32285256 [TBL] [Abstract][Full Text] [Related]
32. APOBEC3A/B deletion polymorphism and endometrial cancer risk. Sofiyeva N; Krakstad C; Halle MK; O'Mara TA; Romundstad P; Hveem K; Vatten L; Lønning PE; Gansmo LB; Knappskog S Cancer Med; 2023 Mar; 12(6):6659-6667. PubMed ID: 36394079 [TBL] [Abstract][Full Text] [Related]
33. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs. Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085 [TBL] [Abstract][Full Text] [Related]
34. Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer. Radmanesh H; Spethmann T; Enßen J; Schürmann P; Bhuju S; Geffers R; Antonenkova N; Khusnutdinova E; Sadr-Nabavi A; Shandiz FH; Park-Simon TW; Hillemanns P; Christiansen H; Bogdanova N; Dörk T Breast Cancer Res Treat; 2017 Feb; 162(1):31-37. PubMed ID: 28062980 [TBL] [Abstract][Full Text] [Related]
35. Variants of estrogen-related genes and breast cancer risk in European and African American women. Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414 [TBL] [Abstract][Full Text] [Related]
36. Involvement of APOBEC3A/B Deletion in Mouse Mammary Tumor Virus (MMTV)-like Positive Human Breast Cancer. de Sousa Pereira N; Vitiello GAF; Amarante MK Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980505 [TBL] [Abstract][Full Text] [Related]
37. Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer. Gansmo LB; Sofiyeva N; Bjørnslett M; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S Sci Rep; 2021 Dec; 11(1):23463. PubMed ID: 34873230 [TBL] [Abstract][Full Text] [Related]
38. Expression of DNA cytosine deaminase APOBEC3 proteins, a potential source for producing mutations, in gastric, colorectal and prostate cancers. Gwak M; Choi YJ; Yoo NJ; Lee S Tumori; 2014; 100(4):112e-7e. PubMed ID: 25296601 [TBL] [Abstract][Full Text] [Related]
39. Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women. Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; John EM; Hines LM; Stern MC; Giuliano AR; Torres-Mejia G; Brock GN; Groves FD; Kerber RA; Wolff RK; Slattery ML Breast Cancer Res Treat; 2013 Sep; 141(2):287-97. PubMed ID: 24036662 [TBL] [Abstract][Full Text] [Related]
40. 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. Milne RL; Lorenzo-Bermejo J; Burwinkel B; Malats N; Arias JI; Zamora MP; Benítez J; Humphreys MK; García-Closas M; Chanock SJ; Lissowska J; Sherman ME; Mannermaa A; Kataja V; Kosma VM; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Anton-Culver H; Ziogas A; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Irwanto AK; Kang D; Yoo KY; Noh DY; Couch FJ; Olson JE; Wang X; Fredericksen Z; Nordestgaard BG; Bojesen SE; Flyger H; Margolin S; Lindblom A; Fasching PA; Schulz-Wendtland R; Ekici AB; Beckmann MW; Wang-Gohrke S; Shen CY; Yu JC; Hsu HM; Wu PE; Giles GG; Severi G; Baglietto L; English DR; Cox A; Brock I; Elliott G; Reed MW; Beesley J; Chen X; Investigators K; ; Fletcher O; Gibson L; dos Santos Silva I; Peto J; Frank B; Heil J; Meindl A; Chang-Claude J; Hein R; Vrieling A; Flesch-Janys D; Southey MC; Smith L; Apicella C; Hopper JL; Dunning AM; Pooley KA; Pharoah PD; Hamann U; Pesch B; Ko YD; ; Easton DF; Chenevix-Trench G J Med Genet; 2011 Oct; 48(10):698-702. PubMed ID: 21931171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]